(ANZSN). To preserve anonymity, the survey was entirely de-identified, both for the respondent and for the patient being reported. Participation was voluntary and informed consent was sought. Returned physical responses were stored in a secure locked cabinets at the Royal Adelaide Hospital, and merged with the online responses securely hosted on secure servers provided by eResearch SA. Results: A response rate of 36.5% yielded 197 responses. 133 (67%) of responding practitioners reported having discussed this practice with their patients, and 105 (53%) practitioners reported having cared for a patient following overseas transplant. A total of 129 patients were reported between the years 1980 and 2018 and the transplants were performed in 17 different countries, with China (n=40, 31.2%), India (n=20, 15.6%), Pakistan (n=11, 8.6%), and the Philippines (n=10, 7.8%) being the most popular destinations. 34% of patients traveled to their country of origin for the transplantation, as is demonstrated by Figure 1. Significant numbers of patients returned with infective complications (25.6%, n=33) with a comparatively low rate of rejection reported in those returning (7.8%, n=10).

In August 2006 the new 20MW low enriched uranium research reactor OPAL went critical. The reactor has 3 main functions, radio pharmaceutical production, silicon irradiation and as a neutron source. Commissioning on 7 neutron scattering instruments began in December 2006. Three of these instruments (Small Angle Neutron Scattering, Reflectometer and Time-of-flight Spectrometer) utilize cold neutrons.The OPAL Cold Neutron Source, located inside the reactor, is a 20L liquid deuterium moderated source operating at 20K, 330kPa with a nominal refrigeration capacity of 5 kW and a peak flux at 4.2meV (equivalent to a wavelength of 0.4nm). The Thermosiphon and Moderator Chamber are cooled by helium gas delivered at 19.8K using the Brayton cycle. The helium is compressed by two 250kW compressors (one with a variable frequency drive to lower power consumption).A 5 Tesla BSCCO (2223) horizontal field HTS magnet will be delivered in the 2 nd half of 2007 for use on all the cold neutron instruments. The magnet is cooled by a pulse tube cryocooler operating at 20K. The magnet design allows for the neutron beam to pass both axially and transverse to the field. Samples will be mounted in a 4K to 800K GiffordMcMahon (GM) cryofurnace, with the ability to apply a variable electric field in-situ. The magnet is mounted onto a tilt stage. The sample can thus be studied under a wide variety of conditions. A cryogen free 7.4 Tesla Nb-Ti vertical field LTS magnet, commissioned in 2005 will be used on neutron diffraction experiments. It is cooled by a standard GM cryocooler operating at 4.2K. The sample is mounted in a 2 nd GM cryocooler (4K-300K) and a variable electric field can be applied. KEYWORDS:Cold neutron source, BSSCO (2223), Bi-2223, cryogen-free, neutron science, HTS magnet, LTS magnet, OPAL. 299ATTACHMENT I CREDIT LINE (BELOW) TO BE INSERTED ON THE FIRST PAGE OF EACH PAPER EXCEPT FOR ARTICLES ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, 1083ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1090ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1359ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1366ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1375ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1382ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1383ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1391ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1467ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1474ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1491ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1498ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1499ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1506ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , 1507ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, -1514ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, , and 1629ON pp. 152 -159, 225 -234, 277 -283, 284 -290, 685 -692, ...